Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Rules - 1999 > Proposed Placement of Zaleplon into Schedule IV - Correction

Rules - 1999

[Federal Register: May 11, 1999 (Volume 64, Number 90)]
[Corrections]
[Page 25405]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr11my99-145]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[DEA-182P]

21 CFR Part 1308

Schedules of Controlled Substances: Proposed Placement of Zaleplon into Schedule IV

Correction

In proposed rule document 99-11289, beginning on page 24094 in the issue of Wednesday May 5, 1999, make the following corrections: 

  1. On page 24094, in the third column, beginning in the eighth line from the bottom, the sentence "Zaleplon-related overdoes were also noted during the clinical trials" is removed.
  2. On the same page, in the same column, in the fifth line from the bottom, "overdoes" should read "overdoses".

[FR Doc. C9-11289 Filed 5-10-99; 8:45 am]

BILLING CODE 4410-09-M

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Printing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility